1-4 of 4
Leanthe Braunert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes Following Hypomethylating Agent / Venetoclax Combination-Therapy for MDS or AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Lara Bischof, Jule Ussmann, Donata Backhaus, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Maximilian Merz, Leanthe Braunert, Doreen Hammerschmidt, Alexander Kühnemund, Anne Weigert, Klaus H. Metzeler, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 4808–4809.
https://doi.org/10.1182/blood-2022-163363
Published: 2022
Journal Articles

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Claudia Nehring, Cornelia Becker, MD, Leanthe Braunert, MD, Sabine Leiblein, Jeanett Edelmann, Georg Franke, MD, Wolfram Poenisch, Thoralf Lange, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2011) 118 (21): 3065.
https://doi.org/10.1182/blood.V118.21.3065.3065
Published: 2011
Journal Articles

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Leanthe Braunert, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Christopher Bredeson, Richard T Maziarz, MD, Michael A. Pulsipher, MD, Edward Agura, MD, Michael T. Maris, MD, Lars Vindelov, MD, Firoozeh Sahebi, M.D., Peter McSweeney, Benedetto Bruno, MD, Amelia Langston, MD, Rainer F. Storb, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 2364.
https://doi.org/10.1182/blood.V116.21.2364.2364
Published: 2010
Journal Articles

Bortezomib in Combination with Bendamustine and Prednisone in the Treatment of Patients with Refractory/Relapsed Multiple Myeloma.

Wolfram Poenisch, MD, Malvina Bourgeois, Song-Yau Wang, Simone Heyn, Nadja Jaekel, Leanthe Braunert, Robert Rohrberg, MD, Hans Juergen Hurtz, MD, Franz Albert Hoffmann, MD, Andreas Schwarzer, MD, Cornelia Becker, MD, Haifa Al Ali, MD, Dietger W. Niederwieser, MD
Journal: Blood
Blood (2007) 110 (11): 2723.
https://doi.org/10.1182/blood.V110.11.2723.2723
Published: 2007